○Sho Takatori¹, Wenbo Wang¹, Akihiro Iguchi¹, Hayato Etani¹, Yung-Ning Chu¹, Aika Akahori¹, Junko Sasaki², Takashi Saito^3,4, Takaomi Saido⁴, Tsuneya Ikezu⁵, Toshiyuki Takai⁶, Takehiko Sasaki², Taisuke Tomita¹ (1. Grad Sch Pharm Sci, Univ of Tokyo, Tokyo, Japan, 2. Med Res Inst, Tokyo Med Dent Univ, Tokyo, Japan, 3. Inst Brain Sci, Grad Sch Med Sci, Nagoya City Univ, Aichi, Japan, 4. RIKEN CBS, Saitama, Japan, 5. Mayo Clinic Florida, FL, USA, 6. Inst Dev Aging Cancer, Tohoku Univ, Sendai, Japan)

○Shoko Hashimoto^1,2, Yukio Matsuba², Kenich Nagata³, Takaomi C. Saido² (1. Medical Innovation Research Center, Shiga University of Medical Science, 2. RIKEN Center for Brain Science, 3. Graduate School of Medicine, Nagoya University)

○Chie Seki¹ (1. National Institutes for Quantum Science and Technology)

○Fumito Endo^1,3, Atsushi Kasai², Gradinaru Viviana⁶, Hitoshi Hashimoto², Riki Kawaguchi⁵, Baljit S Khakh^3,4 (1. Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, 2. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 3. Department of Physiology, University of California Los Angeles, 4. Department of Neurobiology, University of California Los Angeles, 5. Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, 6. Division of Biology and Biological Engineering, California Institute of Technology)